Get started
Author

Andrea Mazzella

Observed names: A Mazzella, A. Mazzella, Mazzella, Andrea
Observed institutions: St George's Hospital, St Thomas' Hospital, St George's, University of London, Duke University, Guy's and St Thomas' NHS Foundation Trust, Churchill Hospital, St George’s University Hospitals NHS Foundation Trust, Federico II University Hospital, Duke Medical Center, Duke University Health System, North Middlesex University Hospital NHS Trust, North Middlesex Hospital, UK Health Security Agency, City St George's, University of London, University College London, University of Virginia, University of Naples Federico II
ORCID: 0000-0003-1560-7465
Observed ORCID: 0000-0003-1560-7465
OpenAlex ID: A5046359756
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
2020 · Merryn Voysey, Sue Ann Costa Clemens, et al. · The Lancet · 4,723
PDF
Single Dose Administration, And The Influence Of The Timing Of The Booster Dose On Immunogenicity and Efficacy Of ChAdOx1 nCoV-19 (AZD1222) Vaccine
2021 · Merryn Voysey, Sue Ann Costa Clemens, et al. · The Lancet · 1,133
PDF
Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial
2021 · Alasdair P S Munro, Leila Janani, et al. · The Lancet · 660
PDF
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial
2021 · Obbina Abani, Ali Abbas, et al. · The Lancet · 512
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2022 · Obbina Abani, Ali Abbas, et al. · The Lancet · 402
Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis
2022 · Obbina Abani, Ali Abbas, et al. · The Lancet · 361
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2021 · Obbina Abani, Ali Abbas, et al. · The Lancet · 303
Safety, immunogenicity, and efficacy of a COVID-19 vaccine (NVX-CoV2373) co-administered with seasonal influenza vaccines: an exploratory substudy of a randomised, observer-blinded, placebo-controlled, phase 3 trial
2021 · Seth Toback, Eva Galiza, et al. · The Lancet Respiratory Medicine · 158
PDF
Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial
2023 · Obbina Abani, Ali Abbas, et al. · The Lancet · 141
Efficacy and Safety of a Booster Regimen of Ad26.COV2.S Vaccine against Covid-19
2022 · Karin Hardt, An Vandebosch, et al. · The Lancet Infectious Diseases · 91
PDF
Durability of ChAdOx1 nCoV-19 vaccination in people living with HIV
2022 · Ane Ogbe, Mathew Pace, et al. · JCI Insight · 59
PDF
Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2023 · O Abani, A Abbas, et al. · The Lancet Diabetes & Endocrinology · 45
PDF
Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial
2024 · Saul N Faust, Richard Haynes, et al. · The Lancet Child & Adolescent Health · 42
PDF
COVID-19-associated pulmonary aspergillosis in mechanically ventilated patients: a prospective, multicentre UK study
2023 · William Hurt, Jonathan Youngs, et al. · Thorax · 36
PDF
National action plans for antimicrobial resistance and variations in surveillance data platforms
2023 · Scott Pallett, Esmita Charani, et al. · Bulletin of the World Health Organization · 25
PDF
HIV-associated disseminated histoplasmosis successfully treated with isavuconazole consolidation therapy
2019 · Andrea Mazzella, Neil R.H. Stone, et al. · Medical Mycology Case Reports · 20
PDF
Viral and Host Factors Are Associated With Mortality in Hospitalized Patients With COVID-19
2024 · Neil R Aggarwal, Jacquie Nordwall, et al. · Clinical Infectious Diseases · 17
PDF
A retrospective analysis of the utility and safety of kidney transplant biopsies by nephrology trainees and consultants
2018 · Michael E. Reschen, Andrea Mazzella, et al. · Annals of Medicine and Surgery · 17
PDF
Screening for dopa-responsive dystonia in patients with scans without evidence of dopaminergic deficiency (SWEDD)
2014 · Anna De Rosa, Claudia Carducci, et al. · Journal of Neurology · 16
Molnupiravir or nirmatrelvir–ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2025 · O Abani, A Abbas, et al. · The Lancet Infectious Diseases · 15
PDF
Transmission dynamics and associated mortality of nosocomial COVID-19 throughout 2021: a retrospective study at a large teaching hospital in London
2023 · L.P.A. Hawkins, S.J.C. Pallett, et al. · Journal of Hospital Infection · 12
PDF
A multisite evaluation of antifungal use in critical care: implications for antifungal stewardship
2022 · C Logan, C Hemsley, et al. · JAC-Antimicrobial Resistance · 11
PDF
Hybrid immunity in older adults is associated with reduced SARS-CoV-2 infections following BNT162b2 COVID-19 immunisation
2023 · Scott J. C. Pallett, Joseph Heskin, et al. · Communications Medicine · 10
PDF
Neutralising antibody titres as predictors of protection against SARS-CoV-2 variants
2021 · Scott J C Pallett, Joseph Heskin, et al. · The Lancet Microbe · 9
The impact of immunosuppressive therapy on secondary infections and antimicrobial use in COVID-19 inpatients: a retrospective cohort study
2023 · Peter Crook, Clare Logan, et al. · BMC Infectious Diseases · 7
PDF
Works count: 40
Citation count: 8,853
H-index: 17
I10-index: 23
Year
Topic
Type